ArticleScientific reports2025

Targeting ADAM17 to dampen dendritic cell-mediated type 2 immune responses and airway inflammation associated with allergic asthma.

Anil Kumar Jaiswal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.